Literature DB >> 8390218

Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma.

A Saitoh1, Y Aoyagi, H Asakura.   

Abstract

Chemical structures of the sugar chains of alpha 1-antitrypsin (AAT) from patients with hepatocellular carcinoma (HCC) and from healthy individuals with a different affinity for Lens culinaris agglutinin (LCA) were examined by pyridylamination of their oligosaccharides and stepwise exoglycosidase digestion in combination with reversed-phase and size-fractionation high-performance liquid chromatography. We found that the LCA-reactive species of AAT from patients with HCC carried both the biantennary sugar chain with a fucose residue at the innermost N-acetylglucosamine residue, Gal beta 1-4GlcNAc beta 1-2Man alpha 1-6(Gal beta 1-4GlcNAc beta 1-2Man alpha 1-3)Man beta 1-4GlcNAc beta 1-4(Fuc alpha 1-6)GlcNAc-PA, and the biantennary chain without a fucose residue, Gal beta 1-4GlcNAc beta 1-2Man alpha 1-6(Gal beta 1-4GlcNAc beta 1-2Man alpha 1-3)Man beta 1-4GlcNAc beta 1-4GlcNAc-PA, at a ratio of about 1:0.6. The LCA-nonreactive species of AAT contained the biantennary sugar chain Gal beta 1-4GlcNAc beta 1-2Man alpha 1-6(Gal beta 1-4GlcNAc beta 1-2Man alpha 1-3)Man beta 1-4GlcNAc beta 1-4GlcNAc as a major component. These results indicate that a characteristic feature of the carbohydrate chains of AAT from patients with HCC is an increment in fucosylation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390218     DOI: 10.1006/abbi.1993.1284

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  11 in total

1.  Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Mengjun Wang; Nikhil Anbarasan; Lucy Betesh; Aykan Karabudak; Ethan Moritz; Karthik Devarajan; Jorge Marrero; Timothy M Block; Anand Mehta
Journal:  Proteomics Clin Appl       Date:  2013-09-13       Impact factor: 3.494

2.  Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum?

Authors:  E C Havenaar; R J Dolhain; G A Turner; M T Goodarzi; E C van Ommen; F C Breedveld; W van Dijk
Journal:  Glycoconj J       Date:  1997-06       Impact factor: 2.916

3.  Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation.

Authors:  P Mills; K Mills; P Clayton; A Johnson; D Whitehouse; B Winchester
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

4.  Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.

Authors:  Timothy M Block; Mary Ann Comunale; Melissa Lowman; Laura F Steel; Patrick R Romano; Claus Fimmel; Bud C Tennant; W Thomas London; Alison A Evans; Baruch S Blumberg; Raymond A Dwek; Tajinder S Mattu; Anand S Mehta
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-10       Impact factor: 11.205

5.  Severe rheumatoid arthritis prohibits the pregnancy-induced decrease in alpha3-fucosylation of alpha1-acid glycoprotein.

Authors:  E C Havenaar; J S Axford; E C Brinkman-van der Linden; A Alavi; E C Van Ommen; B van het Hof; T Spector; A Mackiewicz; W Van Dijk
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

6.  Sialyl Lewis(x) epitopes do not occur on acute phase proteins in mice: relationship to the absence of alpha3-fucosyltransferase in the liver.

Authors:  E C Havenaar; R C Hoff; D H van den Eijnden; W van Dijk
Journal:  Glycoconj J       Date:  1998-04       Impact factor: 2.916

Review 7.  Carbohydrate-based measurements on alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.

Authors:  Y Aoyagi
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

8.  Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by Mammalian cell systems.

Authors:  M Butler
Journal:  Cytotechnology       Date:  2006-06-09       Impact factor: 2.058

9.  Targeted Measurements of O- and N-Glycopeptides Show That Proteins in High Density Lipoprotein Particles Are Enriched with Specific Glycosylation Compared to Plasma.

Authors:  Muchena J Kailemia; Wanghui Wei; Khoa Nguyen; Elizabeth Beals; Lisa Sawrey-Kubicek; Christopher Rhodes; Chenghao Zhu; Romina Sacchi; Angela M Zivkovic; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2017-12-27       Impact factor: 4.466

10.  ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC).

Authors:  Shujuan Pan; Xiaoyun Cheng; Hongan Chen; Patricia D Castro; Michael M Ittmann; Anne W Hutson; Susan K Zapata; Richard N Sifers
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.